News - Regenstrief Institute

Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.

Filtering

June 24, 2019 • Expert Opinion, News

Can Deprescribing Drugs Linked to Cognitive Impairment Actually Reduce Risk of Dementia?

JAMA Internal Medicine commentary highlights opportunity to discover modifiable risk factors for dementia In a commentary published in JAMA Internal Medicine, three Regenstrief Institute research scientists write that while they and other researchers have identified a strong and consistent link between anticholinergic drugs and cognitive impairment from observational studies, randomized clinical trials represent the only […]

May 29, 2019 • Expert Opinion

IHS Modernization: Focus on the Patients, and the Data will Follow

By Gregory Schmidt, MD & Theresa Cullen, MD, MS Healthcare in America is a pairing of extremes. When ranked, the United States has some of the very best and the very worst healthcare metrics. Cancer survival remains the highest of any country, yet maternal deaths and infant deaths rank the worst of all developed nations. […]

Recent Influence

influence

Algorithm developed by Regenstrief/Merck collaboration hailed as promising research tool

Jul 07, 2021

More Info >

influence

Regenstrief experts share cancer-related research as part of IU Simon Cancer Center Series

Jun 22, 2021

More Info >

influence

Dr. Peter Embi in four-box during discussion about health evidence

Regenstrief CEO discusses real-world evidence and health services research at AcademyHealth conference

Jun 17, 2021

More Info >

influence

Career paths in biomedical informatics: Regenstrief president shares his career journey

Jun 02, 2021

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., shared his passion for biomedical informatics as part of a video series highlighting the journeys of graduates from National Library of Medicine T15 training programs.

More Info >

influence